Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.3K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

4.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.2K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

5.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.8K
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

307
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
307

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Menopause age and hypercholesterolemia comorbidities: a region-wide retrospective cohort study in Andalusia, Spain (2016-2022).

BMJ open·2026
Same author

Interrelational Proteomic Sequence Features Enhance Predictive Modeling: Application to COVID-19 Severity.

Biomedicines·2026
Same author

Integrated Transcriptomic and Histological Analysis of TP53/CTNNB1 Mutations and Microvascular Invasion in Hepatocellular Carcinoma.

Genes·2026
Same author

Proteomic Validation of MEG-01-Derived Extracellular Vesicles as Representative Models for Megakaryocyte- and Platelet-Derived Extracellular Vesicles.

Biomolecules·2025
Same author

Clozapine induces perineuronal net remodeling in a developmental mouse model exhibiting schizophrenia-relevant phenotypes.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2025
Same author

Exploring the role of normalization and feature selection in microbiome disease classification pipelines.

GigaScience·2025

Related Experiment Video

Updated: Mar 17, 2026

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
09:35

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

11.7K

High-Fidelity Synthetic Data Replicates Clinical Prediction Performance in a Million-Patient Diabetes Cohort.

Francisco Ortuño1, Víctor M de la Oliva Roque2,3, Javier-Ignacio Ramirez-Lopez1

  • 1Department of Computer Engineering, Automation and Robotics, University of Granada, Granada, Spain.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|March 16, 2026
PubMed
Summary

Synthetic patient data can replicate real-world data performance for research, but careful validation is needed. This study used dual adversarial autoencoders to generate synthetic diabetes data, showing promise for privacy-preserving healthcare research.

Keywords:
algorithmic biasbiomedical plausibilitydiabetesgenerative deep learninglongitudinal patient dataprivacy‐preserving researchsynthetic electronic health records

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K

Related Experiment Videos

Last Updated: Mar 17, 2026

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
09:35

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

11.7K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K

Area of Science:

  • Health Informatics
  • Artificial Intelligence in Medicine
  • Biomedical Data Science

Background:

  • Synthetic patient data are crucial for privacy-preserving clinical research.
  • Ensuring statistical fidelity and biomedical plausibility of synthetic data is challenging.
  • Large-scale real-world clinical datasets are vital for robust research.

Purpose of the Study:

  • To generate longitudinal synthetic patient datasets using a dual adversarial autoencoder.
  • To evaluate the utility and biomedical plausibility of synthetic data for clinical research.
  • To assess the performance of machine learning models trained on synthetic versus real-world data.

Main Methods:

  • Employed a dual adversarial autoencoder to generate synthetic longitudinal data.
  • Utilized real-world clinical data from nearly one million diabetes patients.
  • Conducted multi-faceted evaluations including machine learning tasks and biomedical plausibility assessments.

Main Results:

  • Synthetic data models achieved predictive performance comparable to real data models for chronic kidney disease onset.
  • Feature importance rankings were stable, indicating clinical coherence.
  • Sex-stratified analyses revealed inconsistencies not captured by standard metrics, highlighting the need for domain-specific evaluation.

Conclusions:

  • Synthetic data can effectively replicate predictive performance but require robust validation.
  • A comprehensive validation framework integrating machine learning utility and domain-specific biomedical evaluation is essential.
  • Synthetic data generation supports large-scale, privacy-preserving research and collaborative healthcare data ecosystems.